end coming?January 13, 2010, 5:47 PM ET.
Time Warner Cable: Big Div ComingBy Eric Savitz
Time Warner Cable (TWC) is churning out an enormous out of cash - and some of it seems destined for the pockets of its shareholders.
In a research note earlier today, Bernstein Research analyst Craig Moffett theorized that the company is likely to announce a dividend of $1.50 a share or more in early 2010, for a yield of at least 3.4%. Moffett says, however, that in 2011 and beyond that the cable company will have about $9 a share per year for dividends and buybacks. Ergo, he says, he expects “a sizable share repurchase authorization to accompany the announcement of any size dividend.”
Moffett today repeated his Overweight rating on the stock, which is favorite pick in the cable group, and raised his price target to $60, from $55.
It was an ill-fated attempt at micro-retailing.
Avoiding BBY will only cause you to miss great deals and great service.
News Alert from The Wall Street Journal
The charitable trust that controls Hershey is pushing the chocolate maker to launch a rival $17 billion bid for Cadbury that would be bigger and have more cash than what Kraft Foods has offered.
THANKS HERSHEY, YOU SAVED US (I HOPE)
Their system went down 4 minutes before closing and prevented me from buying some calls going into earnings.
For the record, I wanted to get KFT and PG calls.
Still like the stock for the next three months.
GL to all longs
Shares of Legg Mason (NYSE:LM) jumped 11.25% to $24.52 on news that investor Nelson Peltz bought 12 to 13 million shares, or about 9% of the Baltimore-based firm. Britain's Telegraph newspaper reported the story and said that Peltz may push to break up the firm, citing "well-placed" sources.
Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure.
Pioneer Natural Resources Company (the "Company") today announced that it has reached an agreement to settle claims made against it and its subsidiary in the lawsuit MOSH Holding, L.P. v Pioneer Natural Resources Company; Pioneer Natural Resources USA, Inc.; Woodside Energy (USA) Inc.; and JPMorgan Chase Bank, N.A., as Trustee of the Mesa Offshore Trust (the "Trust"), which is pending before the Judicial District Court of Harris County, Texas (334th Judicial District). A description of the allegations and proceedings in the lawsuit is contained in the Company's Annual Report on Form 10-K for the year ended December 31, 2008 and incorporated herein by reference.
Under the terms of the agreement, Pioneer will pay to the Trust the sum of $13 million (the majority of which has been reserved in prior quarters) in exchange for a full and final release of all claims made or that could have been made in the lawsuit. Pioneer will also contribute to the Trust proceeds obtained from Pioneer's sale of its complete interest, including its working interest, in the Brazos Block A-39 tract, which will be sold in conjunction with the Trust's sale of its assets.
The settlement agreement is subject to customary conditions, including court approval and the dismissal of the case with prejudice.
Except for historical information contained herein, the statements in this Current Report are forward-looking statements that are made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements and the business prospects of Pioneer are subject to a number of risks and uncertainties that may cause Pioneer's actual results in future periods to differ materially from the forward-looking statements. These risks and uncertainties include, among other things, government and third party approvals and litigation. These and other risks are described in Pioneer's 10-K and 10-Q Reports and other filings with the Securities and Exchange Commission.
S&P REITERATES HOLD OPINION ON SHARES OF NEUROCRINE BIOSCIENCES
49 minutes ago - Standard & Poor's Research Notes
NBIX reports positive Phase IIb study results on Elagolix in treating endometriosis. In six-month study, the drug did not induce significant bone loss, while showing strong results in reducing pain symptoms, confirming prior interim analyses. NBIX plans to proceed with oral and once-daily dosing. We believe results should position NBIX to garner favorable program partnership terms. However, we still do not expect Phase III study to begin until late 2009 and do not project approval before 2011. We raise our NPV-based 12-month target price by $1 to $7.
Better yet- short the stock and move the trail to Amarillo and tell em Boone is still connected to PXD. That jury will burn the company.
Boone is hated in most of Amarillo